Current Vascular Pharmacology
Title:Editorial : Full Blood Count and Peripheral Arterial Disease Severity and Prognosis
Volume: 15 Issue: 2
Author(s): Konstantinos Spanos, Miltiadis Matsagkas and Athanasios Giannoukas
Affiliation:
Export Options
About this article
Cite this article as:
Spanos Konstantinos, Matsagkas Miltiadis and Giannoukas Athanasios, Editorial : Full Blood Count and Peripheral Arterial Disease Severity and Prognosis, Current Vascular Pharmacology 2017; 15 (2) . https://dx.doi.org/10.2174/1570161114999161019110003
DOI https://dx.doi.org/10.2174/1570161114999161019110003 |
Print ISSN 1570-1611 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6212 |
Call for Papers in Thematic Issues
Ischemic Cardiovascular Diseases: Mechanisms, Diagnosis and Therapy
Ischemic cardiovascular disease includes myocardial infarction, coronary atherosclerotic heart disease, angina pectoris, etc., constitute the leading cause of patient mortality by preventing tissues from getting sufficient oxygen and nutrients. Ischemic heart disease, as a clinical condition, is characterized by myocardial ischemia, causing an imbalance between myocardial blood supply and demand, ...read more
TREATMENT OF CARDIOVASCULAR DISEASE IN CHRONIC AND END STAGE KIDNEY DISEASE
Cardiovascular disease still remains the leading cause of death in Chronic and End Stage Kidney Disease, accounting for more than half of all deaths in dialysis patients. During the past decade, research has been focused on novel therapeutic agents that might delay or even reverse cardiovascular disease and vascular calcification, ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Extracts and Flavonoids of <i>Passiflora</i> Species as Promising Anti-inflammatory and Antioxidant Substances
Current Pharmaceutical Design Oxidised Products of Cholesterol: Their Role in Apoptosis
Current Nutrition & Food Science Regenerative Treatment in Spinal Cord Injury
Current Stem Cell Research & Therapy Pediatric CKD and Cardivascular Disease
Cardiovascular & Hematological Disorders-Drug Targets Targeting TRPs in Neurodegenerative Disorders
Current Topics in Medicinal Chemistry Cardiovascular Complications in Diabetes: Lessons from Animal Models
Current Medicinal Chemistry Misfolded Proteins and Human Diseases
Protein & Peptide Letters Novel Therapeutic Strategies Targeting Vascular Redox in Human Atherosclerosis
Recent Patents on Cardiovascular Drug Discovery Histone Deacetylase Inhibitors in Psoriasis Therapy
Current Drug Targets - Inflammation & Allergy Coumarins as Promising Scaffold for the Treatment of Age-related Diseases – An Overview of the Last Five Years
Current Topics in Medicinal Chemistry Niemann-Pick C1-Like 1 (NPC1L1) Inhibition and Cardiovascular Diseases
Current Medicinal Chemistry The Cardiac Microvasculature in Hypertension, Cardiac Hypertrophy and Diastolic Heart Failure
Current Vascular Pharmacology Evaluation of Inferior Phrenic Artery Variations of 1029 Patients Using MDCT Angiography
Current Medical Imaging Carotid Artery Atherosclerosis: What is the Evidence for Drug Action?
Current Pharmaceutical Design Angiogenesis, Neurogenesis and Neuroplasticity in Ischemic Stroke
Current Cardiology Reviews Infections and Atheromatous Plaque: Current Therapeutic Implications
Current Pharmaceutical Design Ethanol and Inflammation
Anti-Inflammatory & Anti-Allergy Agents in Medicinal Chemistry The Renin-Angiotensin System in the Mammalian Central Nervous System
Current Protein & Peptide Science Stem Cell Therapy for Ischaemic Stroke: Translation from Preclinical Studies to Clinical Treatment
CNS & Neurological Disorders - Drug Targets Pharmacological Overview and Future Perspectives of Cholinergic Therapy in Alzheimers Disease
Current Drug Therapy